Regions of mouse mammary tumor virus superantigen involved in interaction with the major histocompatibility complex class II I-A molecule

Journal of Virology

Volumn 76, Issue 21, 2002, Pages 11172-11175

  Wirth, Susanne ^a   Vessaz, Annelyse ^a   Krummenacher, Claude ^a   Baribaud, Frédéric ^a   Acha Orbea, Hans ^a   Diggelmann, Heidi ^a  

^a Institute of Microbiology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; SUPERANTIGEN MTV 7; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE CONSTRUCT; HYBRID; MOLECULAR INTERACTION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; MAMMARY TUMOR VIRUS, MOUSE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT FUSION PROTEINS; SUPERANTIGENS;

EID: 0036839177     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.21.11172-11175.2002     Document Type: Article

References (11)

1. Acha-Orbea, H., R. M. Zinkernagel, and H. Hengartner. 1985. Cytotoxic T cell clone-specific monoclonal antibodies used to select clonotypic antigen-specific cytotoxic T cells. Eur. J. Immunol. 15:31-36.
2. β domains. J. Virol. 75:7453-7461.
3. Blochlinger, K., and H. Diggelmann. 1992. Expression of the mouse mammary tumor virus ORF gene in cultured cells. Int. Rev. Immunol. 8:337-355.
4. Hsu, P.-N., P. Wolf Bryant, N. Sutkowski, B. McLellan, H. L. Ploegh, and B. T. Huber. 2001. Association of mouse mammary tumor virus superantigen with MHC class II during biosynthesis. J. Immunol. 166:3309-3314.
5. Krummenacher, C., and H. Diggelmann. 1993. The mouse mammary tumor virus long terminal repeat encodes a 47 kDa glycoprotein with a short half-life in mammalian cells. Mol. Immunol. 30:1151-1157.
6. Krummenacher, C., H. Diggelmann, and H. Acha-Orbea. 1996. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen. J. Virol. 70:3026-3031.
7. Le Meur, M., P. Gerlinger, C. Benoist, and D. Mathis. 1985. Correcting an immune-response deficiency by creating E alpha gene transgenic mice. Nature 316:38-42.
8. Luther, S. A., and H. Acha-Orbea. 1997. Mouse mammary tumor virus: immunological interplays between virus and host. Adv. Immunol. 65:139-243.
9. McMahon, C. W., B. Traxler, M. E. Grigg, and A. M. Pullen. 1998. Transposon-mediated random insertions and site-directed mutagenesis prevent the trafficking of a mouse mammary tumor virus superantigen. Virology 243:354-365.
10. Mottershead, D. G., P. N. Hsu, R. G. Urban, J. L. Strominger, and B. T. Huber. 1995. Direct binding of the Mtv7 superantigen (Mls-1) to soluble MHC class II molecules. Immunity 2:149-154.
11. Torres, B. A., N. D. Griggs, and H. M. Johnson. 1993. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens. Nature 364:152-154.